RFPL3S
Putative protein RFPL3S
Also known as: RFL3S_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for RFPL3S in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
107 residues, UniProt reviewed canonical sequence.
>P0C7P2|RFPL3S
1 MQTDTSNLSA RSCRFCVMSP LRTLLRSSEM RRKLLAVSAS KVISTVKRKT SCSASGQKPT
61 PCLSSTSKAQ ISPDFSFFNS VSSSKIKTFH EETSLFQIFI GMLCGNTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFPL3S can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 0.52
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFPL3S as an antibody target. Whether an autoantibody or antibody against RFPL3S could matter depends on whether native RFPL3S is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFPL3S is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFPL3S as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...